<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37019477</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>07</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>14</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">2053-8790</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Lupus science &amp; medicine</Title><ISOAbbreviation>Lupus Sci Med</ISOAbbreviation></Journal><ArticleTitle>Infection-related hospitalisation in young adults with systemic lupus erythematosus: data from the National Inpatient Sample.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e000851</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/lupus-2022-000851</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Care of young adults with SLE (YA-SLE, 18-24 years) is challenging due to major life transitions co-occurring with chronic healthcare needs. Studies have demonstrated poorer outcomes in the post-transition period. Epidemiological studies focused on serious infection-related hospitalisation (SIH) in YA-SLE are lacking.</AbstractText><AbstractText Label="METHODS">We used National Inpatient Sample from 2010 to 2019 to study the epidemiology and outcomes of SIH for five common infections in SLE, namely sepsis, pneumonia, urinary tract infections, skin and soft tissue infections, and opportunistic infections. For time trends, we extended the dataset to cover 2000-2019. The primary outcome was the rate of SIH in YA-SLE compared with adults (25-44 years) with SLE and with young adults without SLE (YA-no SLE).</AbstractText><AbstractText Label="RESULTS">From 2010 to 2019, we identified 1&#x2009;720&#x2009;883 hospital admissions with SLE in patients aged &#x2265;18 years. Rates of SIH were similar in young adults and adults with SLE (15.0% vs 14.5%, p=0.12), but considerably higher than in the YA-no SLE group (4.2%, p&lt;0.001). Among SLE with SIH, sepsis followed by pneumonia was the most common diagnosis. Significantly higher proportions of SIH among young adults than adults with SLE were comprised of non-white patients, belonged to the lowest income quartile and had Medicaid. However, only race/ethnicity was associated with SIH among YA-SLE. There was a higher prevalence of comorbid lupus nephritis and pleuritis among young adults compared with adults with SLE and SIH, and both comorbidities were associated with SIH in YA-SLE. Increasing rates of SIH, driven by sepsis, were seen over time.</AbstractText><AbstractText Label="DISCUSSION">YA- SLE had similar rates of SIH to adults with SLE. While hospitalised YA-SLE differed sociodemographically from SLE adults and YA-no SLE, only race/ethnicity was associated with SIH in the YA-SLE group. Lupus nephritis and pleuritis were associated with higher SIH in YA-SLE. Among SLE with SIH, increasing trends of sepsis deserve further study.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dhital</LastName><ForeName>Rashmi</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-1974-7844</Identifier><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine, UCSD, La Jolla, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guma</LastName><ForeName>Monica</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine, UCSD, La Jolla, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Rheumatology, VA San Diego Health Care System, San Diego, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poudel</LastName><ForeName>Dilli R</ForeName><Initials>DR</Initials><AffiliationInfo><Affiliation>Department of Medicine, Indiana Regional Medical Center, Indiana, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chambers</LastName><ForeName>Christina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Environmental Science and Health, Department of Pediatrics, UCSD, La Jolla, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalunian</LastName><ForeName>Kenneth</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine, UCSD, La Jolla, California, USA kkalunian@health.ucsd.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>T32 AR064194</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lupus Sci Med</MedlineTA><NlmUniqueID>101633705</NlmUniqueID><ISSNLinking>2053-8790</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008181" MajorTopicYN="Y">Lupus Nephritis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007297" MajorTopicYN="N">Inpatients</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010998" MajorTopicYN="Y">Pleurisy</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011014" MajorTopicYN="Y">Pneumonia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Epidemiology</Keyword><Keyword MajorTopicYN="N">Infections</Keyword><Keyword MajorTopicYN="N">Lupus Erythematosus, Systemic</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>7</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>5</Day><Hour>20</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37019477</ArticleId><ArticleId IdType="pmc">PMC10083864</ArticleId><ArticleId IdType="doi">10.1136/lupus-2022-000851</ArticleId><ArticleId IdType="pii">10/1/e000851</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hochberg MC, Boyd RE, Ahearn JM, et al. . Systemic lupus erythematosus: a review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets. Medicine (Baltimore) 1985;64:285&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">2412088</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadun RE, Schanberg LE. Transition and transfer of the patient with paediatric-onset lupus: a practical approach for paediatric and adult rheumatology practices. Lupus Sci Med 2018;5:e000282. 10.1136/lupus-2018-000282</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/lupus-2018-000282</ArticleId><ArticleId IdType="pmc">PMC6109813</ArticleId><ArticleId IdType="pubmed">30167316</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy DM, Peschken CA, Tucker LB, et al. . Influence of ethnicity on childhood-onset systemic lupus erythematosus: results from a multiethnic multicenter Canadian cohort. Arthritis Care Res (Hoboken) 2013;65:152&#x2013;60. 10.1002/acr.21779</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acr.21779</ArticleId><ArticleId IdType="pmc">PMC3469777</ArticleId><ArticleId IdType="pubmed">22744999</ArticleId></ArticleIdList></Reference><Reference><Citation>Manadan AM, Kambhatla S, Gauto-Mariotti E, et al. . Reasons for hospitalization and in-hospital mortality in adult systemic lupus erythematosus. ACR Open Rheumatol 2020;2:683&#x2013;9. 10.1002/acr2.11195</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acr2.11195</ArticleId><ArticleId IdType="pmc">PMC7672299</ArticleId><ArticleId IdType="pubmed">33164350</ArticleId></ArticleIdList></Reference><Reference><Citation>Barber MRW, Clarke AE. Systemic lupus erythematosus and risk of infection. Expert Rev Clin Immunol 2020;16:527&#x2013;38. 10.1080/1744666X.2020.1763793</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1744666X.2020.1763793</ArticleId><ArticleId IdType="pubmed">32478627</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhital R, Pandey RK, Poudel DR, et al. . All-cause hospitalizations and mortality in systemic lupus erythematosus in the US: results from a national inpatient database. Rheumatol Int 2020;40:393&#x2013;7. 10.1007/s00296-019-04484-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-019-04484-5</ArticleId><ArticleId IdType="pubmed">31773392</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrinton LJ, Liu L, Goldfien R, et al. . Risk of serious infection for patients with systemic lupus erythematosus starting glucocorticoids with or without antimalarials. J Rheumatol 2016;43:1503&#x2013;9. 10.3899/jrheum.150671</Citation><ArticleIdList><ArticleId IdType="doi">10.3899/jrheum.150671</ArticleId><ArticleId IdType="pubmed">27370880</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen T, Reda S, Martin S, et al. . The needs of adolescents and young adults with chronic illness: results of a quality improvement survey. Children (Basel) 2022;9:500. 10.3390/children9040500</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/children9040500</ArticleId><ArticleId IdType="pmc">PMC9025253</ArticleId><ArticleId IdType="pubmed">35455544</ArticleId></ArticleIdList></Reference><Reference><Citation>Son MB, Sergeyenko Y, Guan H, et al. . Disease activity and transition outcomes in a childhood-onset systemic lupus erythematosus cohort. Lupus 2016;25:1431&#x2013;9. 10.1177/0961203316640913</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203316640913</ArticleId><ArticleId IdType="pmc">PMC5035166</ArticleId><ArticleId IdType="pubmed">27013665</ArticleId></ArticleIdList></Reference><Reference><Citation>Pratsidou-Gertsi P. Transition of the patient with childhood-onset SLE. MJR 2016;27:94&#x2013;7. 10.31138/mjr.27.3.94</Citation><ArticleIdList><ArticleId IdType="doi">10.31138/mjr.27.3.94</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh JA, Cleveland JD. Hospitalized infections in lupus: a nationwide study of types of infections, time trends, health care utilization, and in-hospital mortality. Arthritis Rheumatol 2021;73:617&#x2013;30. 10.1002/art.41577</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.41577</ArticleId><ArticleId IdType="pubmed">33142044</ArticleId></ArticleIdList></Reference><Reference><Citation>NIS trend weights. Available: https://www.hcup-us.ahrq.gov/db/nation/nis/trendwghts.jsp [Accessed 13 Oct 2022].</Citation></Reference><Reference><Citation>Hanly JG, Thompson K, Skedgel C. Identification of patients with systemic lupus erythematosus in administrative healthcare databases. Lupus 2014;23:1377&#x2013;82. 10.1177/0961203314543917</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203314543917</ArticleId><ArticleId IdType="pubmed">25057038</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang JC, Xiao R, Knight AM, et al. . A population-based study of risk factors for heart failure in pediatric and adult-onset systemic lupus erythematosus. Semin Arthritis Rheum 2020;50:527&#x2013;33. 10.1016/j.semarthrit.2020.03.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semarthrit.2020.03.019</ArticleId><ArticleId IdType="pmc">PMC7492402</ArticleId><ArticleId IdType="pubmed">32446021</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasonov E, Soloviev S, Davidson JE, et al. . The prevalence and incidence of systemic lupus erythematosus (SLE) in selected cities from three Commonwealth of independent states countries (the Russian Federation, Ukraine and kazakhstan). Lupus 2014;23:213&#x2013;9. 10.1177/0961203313512881</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203313512881</ArticleId><ArticleId IdType="pubmed">24255073</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiese AD, Griffin MR, Stein CM, et al. . Validation of discharge diagnosis codes to identify serious infections among middle age and older adults. BMJ Open 2018;8:e020857. 10.1136/bmjopen-2017-020857</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2017-020857</ArticleId><ArticleId IdType="pmc">PMC6009457</ArticleId><ArticleId IdType="pubmed">29921683</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo Re V, Carbonari DM, Jacob J, et al. . Validity of ICD-10-CM diagnoses to identify hospitalizations for serious infections among patients treated with biologic therapies. Pharmacoepidemiol Drug Saf 2021;30:899&#x2013;909. 10.1002/pds.5253</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.5253</ArticleId><ArticleId IdType="pubmed">33885214</ArticleId></ArticleIdList></Reference><Reference><Citation>Available: https://www.hcup-us.ahrq.gov/db/vars/race/nisnote.jsp [Accessed 13 Dec 2022].</Citation></Reference><Reference><Citation>Healthcare cost and utilization project (HCUP) NIS notes. Available: https://www.hcup-us.ahrq.gov/db/vars/zipinc_qrtl/nisnote.jsp [Accessed 13 Dec 2022].</Citation></Reference><Reference><Citation>Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613&#x2013;9. 10.1016/0895-4356(92)90133-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0895-4356(92)90133-8</ArticleId><ArticleId IdType="pubmed">1607900</ArticleId></ArticleIdList></Reference><Reference><Citation>Chibnik LB, Massarotti EM, Costenbader KH. Identification and validation of lupus nephritis cases using administrative data. Lupus 2010;19:741&#x2013;3. 10.1177/0961203309356289</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203309356289</ArticleId><ArticleId IdType="pmc">PMC2964351</ArticleId><ArticleId IdType="pubmed">20179167</ArticleId></ArticleIdList></Reference><Reference><Citation>Li T, Lee I, Jayakumar D, et al. . Development and validation of lupus nephritis case definitions using United States Veterans Affairs electronic health records. Lupus 2021;30:518&#x2013;26. 10.1177/0961203320973267</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203320973267</ArticleId><ArticleId IdType="pubmed">33176569</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward MM, Pajevic S, Dreyfuss J, et al. . Short-term prediction of mortality in patients with systemic lupus erythematosus: classification of outcomes using random forests. Arthritis Rheum 2006;55:74&#x2013;80. 10.1002/art.21695</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.21695</ArticleId><ArticleId IdType="pubmed">16463416</ArticleId></ArticleIdList></Reference><Reference><Citation>Jinno S, Lu N, Jafarzadeh SR, et al. . Trends in hospitalizations for serious infections in patients with rheumatoid arthritis in the US between 1993 and 2013. Arthritis Care Res (Hoboken) 2018;70:652&#x2013;8. 10.1002/acr.23328</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acr.23328</ArticleId><ArticleId IdType="pmc">PMC5776053</ArticleId><ArticleId IdType="pubmed">28732148</ArticleId></ArticleIdList></Reference><Reference><Citation>Corporate Finance Institute . Variance inflation factor (VIF). Available: https://corporatefinanceinstitute.com/resources/data-science/variance-inflation-factor-vif/ [Accessed 24 Dec 2022].</Citation></Reference><Reference><Citation>StataCorp . Stata statistical software: release 13. College Station, TX: StataCorp LP, 2013.</Citation></Reference><Reference><Citation>Healthcare Cost and Utilization Project (HCUP) . HCUP databases. Rockville, MD: 
Agency for Healthcare Research and Quality; Available: www.hcup-us.ahrq.gov/nisoverview.jsp [Accessed 31 Dec 2017].</Citation></Reference><Reference><Citation>Joinpoint regression program - surveillance research program. Available: https://surveillance.cancer.gov/joinpoint/ [Accessed 05 May 2019].</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>